[HTML][HTML] Chikungunya vaccine development, challenges, and pathway toward public health impact
C Maure, K Khazhidinov, H Kang, M Auzenbergs… - Vaccine, 2024 - Elsevier
Chikungunya is a neglected tropical disease of growing public health concern with
outbreaks in more than 114 countries in Asia, Africa, Americas, Europe, and Oceania since …
outbreaks in more than 114 countries in Asia, Africa, Americas, Europe, and Oceania since …
[HTML][HTML] Multi-Antigen Elephant Endotheliotropic Herpesvirus (EEHV) mRNA Vaccine Induces Humoral and Cell-Mediated Responses in Mice
JR Watts, JLS Clinton, J Pollet, R Peng, J Tan, PD Ling - Vaccines, 2024 - mdpi.com
Background/Objectives: Elephant endotheliotropic herpesvirus (EEHV) causes lethal
hemorrhagic disease (HD) in Asian and African elephants in human care and the wild. It is …
hemorrhagic disease (HD) in Asian and African elephants in human care and the wild. It is …
Vector induced humoral responses after rVSVΔG-ZEBOV-GP immunization identify vaccinated individuals and correlate with Ebola virus glycoprotein antibodies
Background The robustness and persistence of vaccine antigen-induced antibodies are
often used as proxy indicators of vaccine efficacy, but immune responses to vaccine vectors …
often used as proxy indicators of vaccine efficacy, but immune responses to vaccine vectors …
[HTML][HTML] Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent …
Abstract Objectives As the SARS-CoV-2 virus evolves more rapidly than vaccines are
updated, T cell immunity potentially confers protection against disease progression and …
updated, T cell immunity potentially confers protection against disease progression and …
Factors influencing the time to COVID-19 antigen tests negative conversion among students at a Chinese university: a retrospective analysis
W Liu, Y Jin, Y Wu, Z Xiao, Y Xu, Z Du, J Xiao… - BMC Infectious …, 2024 - Springer
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause
repeated infections. China experienced an outbreak of COVID-19 (coronavirus disease …
repeated infections. China experienced an outbreak of COVID-19 (coronavirus disease …
[HTML][HTML] Ensitrelvir for the treatment of COVID-19: Final analysis of a post-marketing surveillance from Japan
N Hayashi, E Tsukimura, E Ogura - Journal of Infection and Chemotherapy, 2024 - Elsevier
Background Ensitrelvir received approval in Japan for emergency use in the management of
patients with coronavirus disease (COVID-19) in November 2022. A post-marketing …
patients with coronavirus disease (COVID-19) in November 2022. A post-marketing …